Dysbiotic colonic gut microbial community

The dysbiotic colonic gut microbial community refers to a pathological state of the intestinal ecosystem characterized by a loss of taxonomic diversity and an imbalance between beneficial and harmful microorganisms (PubMed: 30535609). In a healthy state, the colonic microbiota performs essential functions such as the fermentation of dietary fibers into short-chain fatty acids, the synthesis of vitamins, and the maintenance of the intestinal epithelial barrier (NIH: Gut Microbiome). Dysbiosis is a key driver in the pathogenesis of numerous diseases, most notably Clostridioides difficile infection, inflammatory bowel disease, and various metabolic disorders (StatPearls: Dysbiosis). As a therapeutic target, the community is addressed through ecological restoration using live biotherapeutic products, fecal microbiota transplantation, and targeted prebiotics (FDA: Vowst Approval). Drugs like Vowst and Rebyota are specifically designed to restore a healthy microbial balance to prevent the recurrence of infection. Challenges in targeting this community include high inter-individual variability and the risk of introducing opportunistic pathogens during treatment.

Other names

Gut dysbiosisIntestinal dysbiosisColonic dysbiosisAltered gut microbiotaMicrobial imbalance

Restoration of microbial diversity and ecological balance to provide competitive exclusion of pathogens and normalize host-microbe metabolic and immune signaling (FDA: Vowst; PubMed: 30535609).